Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03606174 |
|---|---|
| Brief Title: | A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma |
| First Submitted : | July 20, 2018 |
| First Submitted that Met QC Criteria : | July 20, 2018 |
| First Posted : | July 30, 2018 |
| Results First Submitted : | August 3, 2023 |
| Results First Submitted that Met QC Criteria : | August 3, 2023 |
| Results First Posted : | August 24, 2023 |
| Last Update Submitted that Met QC Criteria : | August 3, 2023 |
| Last Update Posted : | August 24, 2023 |